ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2019

Dual GIP-GLP1-Receptor Agonists In The Treatment Of Type 2 Diabetes: A Short Review On Emerging Data And Therapeutic Potential.

Marie Bastin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.